Methods for detecting prostate cancerMethods for detecting, diagnosing, and monitoring cancerous conditions and/or metastatic diseases such as prostate cancer are disclosed. Angiogenin expression is used to identify cancerous conditions and/or metastatic diseases such as prostate cancer.James Fett...
METHODS OF DETECTING AND TREATING CANCERS CHARACTERIZED BY LOSS OF MIR15 AND MIR16 EXPRESSION Provided herein are, in various embodiments, methods of predicting a likelihood of a subject developing an acute myeloid leukemia (AML) or blast crisis (BC... CM Croce 被引量: 0发表: 2021年 A unifi...
The present invention relates to compositions and methods for detecting cancer (e.g., prostate cancer) and for inhibiting metastasis (e.g., associated with prostate cancer). In particular, the present invention provides methods of detecting vimentin expression and secretion and for characterizing cance...
Enriched CCSCs from colon cancer patients grew primary spheroids, suggesting the presence of tumor-initiating cells in the blood of these patients. In conclusion, we have developed a novel diagnostic assay for detecting CSCs in circulation, which may more accurately predict the risk of relapse or ...
A novel diagnostic tool, developed in recent years, consists of measuring the rare circulating tumor cells (CTCs) in the blood of patients for detecting early stage metastasis or recurrence of cancer in treated patients. This assay is based on the notion that metastatic cancer cells, going ...
In recent years, Hi-C technology has revolutionized cancer research by elucidating the mystery of three-dimensional chromatin organization and its role in gene regulation. This paper explored the impact of Hi-C advancements on cancer research by delving
cells expressing it, methods for targeting and/or inhibiting the growth of cells bearing mesothelin, methods for detecting the antigen and its expression level as an indication of the presence of tumor cells, and kits for such detection... Pastan,Ira, Chang,Kai - WO 被引量: 77发表: 0年 ...
A method is described for detecting lung cancer comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject at risk for developing l
These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, in vivo imaging, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the prostate, such as prostate cancer. Also provided are antibodies which ...
In alternative embodiments, the disclosure herein provides methods for determining the prognosis or malignant potential of a cancer, comprising: (a) (i) providing at least one or a plurality of CSCs, or at least one or a plurality of CSCs from a niche; (ii) detecting and quantifying in the...